Corvus Pharmaceuticals, Inc.
CRVS
$7.60
-$0.22-2.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.71% | 57.49% | 99.80% | 91.40% | 29.48% |
| Total Receivables | 56.56% | 112.30% | 291.38% | 242.86% | 342.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.53% | -33.93% | 105.26% | 25.33% | -24.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.78% | 102.33% | 30.38% | 376.15% | 82.09% |
| Total Current Assets | 55.97% | 57.03% | 99.08% | 94.62% | 29.69% |
|
|
|||||
| Total Current Assets | 55.97% | 57.03% | 99.08% | 94.62% | 29.69% |
| Net Property, Plant & Equipment | 152.31% | 63.77% | 16.88% | -4.12% | -73.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 238.10% | 385.27% | 606.74% | 610.11% | 183.15% |
| Total Assets | 36.83% | 38.57% | 48.28% | 51.27% | 13.23% |
|
|
|||||
| Total Accounts Payable | 5.39% | 158.62% | -18.71% | 69.31% | 33.40% |
| Total Accrued Expenses | 35.20% | 14.56% | -8.14% | -7.76% | -11.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.06% | -49.29% | -69.33% | -86.54% | -73.50% |
| Total Finance Division Other Current Liabilities | -98.60% | -95.29% | 2,177.65% | 11,817.96% | 15,306.87% |
| Total Other Current Liabilities | -98.60% | -95.29% | 2,177.65% | 11,817.96% | 15,306.87% |
| Total Current Liabilities | -82.60% | -36.22% | 38.08% | 415.39% | 535.79% |
|
|
|||||
| Total Current Liabilities | -82.60% | -36.22% | 38.08% | 415.39% | 535.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -81.24% | -30.76% | 50.49% | 429.03% | 506.38% |
|
|
|||||
| Common Stock & APIC | 18.78% | 18.61% | 15.29% | 15.09% | 6.49% |
| Retained Earnings | -3.92% | -13.09% | -12.16% | -18.61% | -17.32% |
| Treasury Stock & Other | -43.63% | 15.28% | 1.65% | -33.20% | 48.86% |
| Total Common Equity | 478.35% | 56.62% | 47.84% | -15.81% | -71.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 478.35% | 56.62% | 47.84% | -15.81% | -71.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 478.35% | 56.62% | 47.84% | -15.81% | -71.98% |
|
|
|||||